Cemtrex Inc. Stock News

Brooklyn, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) --  – Cemtrex Inc. (Nasdaq: CETX, CETXP), an advanced security technology and industrial services company, today announced it will participate at the L

Cemtrex, Inc. (NASDAQ:CETX ) Q2 2023 Earnings Conference Call May 11, 2023 5:00 PM ET Company Participants Saagar Govil – Chief Executive Officer Paul Wyckoff – Chief Financial Officer Conference

Cemtrex Inc. (CETX) came out with a quarterly loss of $0.75 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $6.99 per share a year ago.

Cemtrex, Inc. (NASDAQ:CETX ) Q1 2023 Earnings Conference Call February 14, 2023 5:00 PM ET Company Participants Saagar Govil - Chief Executive Officer Paul Wyckoff - Chief Financial Officer Conference

Brooklyn, NY, Feb. 07, 2023 (GLOBE NEWSWIRE) --  - Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial services company, will hold a conference call on Tuesday, Febru

Brooklyn, NY, Feb. 07, 2023 (GLOBE NEWSWIRE) --  - Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial services company, will hold a conference call on Tuesday, Februar

As much as we may recognize that short sellers perform a valuable service for the equities market, the concept of targeting short-squeeze stocks to buy just to penalize the pessimists carries catharti

Brooklyn, NY , Jan. 23, 2023 (GLOBE NEWSWIRE) --  - Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial services company, today announced that the planned split of it

Brooklyn, NY, Jan. 20, 2023 (GLOBE NEWSWIRE) --  - Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial services company, today announced that effective at 12:01 a.m.,

Existing Border Protection Customer in Texas to Install New Surveillance Equipment Existing Border Protection Customer in Texas to Install New Surveillance Equipment

Cemtrex, Inc. (NASDAQ:CETX ) Q4 2022 Earnings Conference Call January 5, 2023 5:00 PM ET Company Participants Saagar Govil - CEO Paul Wyckoff - CFO Conference Call Participants Jason Kolbert - Dawson

Fiscal Full Year 2022 Revenue Increased 17% to a $50.3M Fiscal Full Year 2022 Revenue Increased 17% to a $50.3M

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. Maxar Technologies Inc. (NYSE: MAXR) shares jumped 12

20 Year Operations Veteran to Lead Operational Growth, Oversee Sales and Engineering, and Spearhead Efficiency Initiatives 20 Year Operations Veteran to Lead Operational Growth, Oversee Sales and Engi

Third Quarter Revenues Increase 32% to $13.6 Million, Management to Host Webcast and Conference Call Today At 5:00 p.m. ET Third Quarter Revenues Increase 32% to $13.6 Million, Management to Host Webc